Diferencia entre revisiones de «Sexually transmitted diseases»
Sin resumen de edición |
|||
| (No se muestran 9 ediciones intermedias de 2 usuarios) | |||
| Línea 2: | Línea 2: | ||
*STD Prevalence: [[Human papillomavirus|HPV]] > [[Human papillomavirus|HSV-2]] > [[Trichomonas]] > [[Chlamydia trachomatis|Chlamydia]] > [[HIV]] > [[HBV]] > [[Neisseria gonorrhoeae|Gonorrhea]] > [[Syphilis]] | *STD Prevalence: [[Human papillomavirus|HPV]] > [[Human papillomavirus|HSV-2]] > [[Trichomonas]] > [[Chlamydia trachomatis|Chlamydia]] > [[HIV]] > [[HBV]] > [[Neisseria gonorrhoeae|Gonorrhea]] > [[Syphilis]] | ||
*STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphilis > [[HIV]] > HBV <ref>[http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf CDC: STI Fact sheet 2013]</ref> | *STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphilis > [[HIV]] > HBV <ref>[http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf CDC: STI Fact sheet 2013]</ref> | ||
==Clinical Features== | ==Clinical Features== | ||
| Línea 14: | Línea 12: | ||
==Evaluation== | ==Evaluation== | ||
==[[ | ==Management <ref> https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf </ref>== | ||
*Consider empiric treatment for [[Gonorrhea]] and [[Chlamydia]]: | |||
**[[Ceftriaxone]] 500 mg IM x1 (1g IM for pts > 150 kg) '''AND''' | |||
**[[Doxycycline]] 100mg PO BID x 7 days (preferred) '''OR''' | |||
**[[Azithromycin]] 1g PO x 1 (alternative regimen) '''OR''' | |||
**[[Azithromycin]] 500 mg PO x 1 and 250mg PO daily x 4 days | |||
*It is important to treat sexual partners for all STDs | |||
**See [[Expedited Partner Therapy]] | |||
== | ==Disposition== | ||
==See Also== | ==See Also== | ||
| Línea 38: | Línea 31: | ||
*[[Pelvic pain]] | *[[Pelvic pain]] | ||
*[[Expedited Partner Therapy]] | *[[Expedited Partner Therapy]] | ||
==External Links== | |||
==References== | ==References== | ||
Revisión actual - 16:16 28 jul 2022
Background
- STD Prevalence: HPV > HSV-2 > Trichomonas > Chlamydia > HIV > HBV > Gonorrhea > Syphilis
- STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphilis > HIV > HBV [1]
Clinical Features
STD Visual Diagnosis (Male)
Primary Syphilis
Painless genital ulcer from lymphogranuloma venereum
Inguinal femoral lymphadenopathy (bilateral) from lymphogranuloma venereum
STD Visual Diagnosis (Female)
Differential Diagnosis
Sexually transmitted diseases
- Chancroid
- Chlamydia trachomatis
- Granuloma inguinale
- Hepatitis B
- Herpes Simplex Virus-2
- HIV
- Human papillomavirus
- Lymphogranuloma venereum
- Neisseria gonorrhoeae
- Trichomonas
- Syphilis
Evaluation
Management [2]
- Consider empiric treatment for Gonorrhea and Chlamydia:
- Ceftriaxone 500 mg IM x1 (1g IM for pts > 150 kg) AND
- Doxycycline 100mg PO BID x 7 days (preferred) OR
- Azithromycin 1g PO x 1 (alternative regimen) OR
- Azithromycin 500 mg PO x 1 and 250mg PO daily x 4 days
- It is important to treat sexual partners for all STDs
Disposition
See Also
- Human Papillomavirus (HPV)
- Pelvic Inflammatory Disease (PID)
- Ulcerative STDs
- Penile diagnoses
- Pelvic pain
- Expedited Partner Therapy